SCHEMBL7184841

SCHEMBL7184841

COCCOc1cc(OCCOC)c(PC(=O)c2c(C)cccc2Cl)c(OCCOC)c1.[LiH]

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.39
KDM4E B2RXH2 3/20 0.39
ALDH1A1 P00352 1/20 0.39
RAB9A P51151 2/20 0.37
GAA P10253 1/20 0.37
MAPT P10636 1/20 0.37
ABL1 P00519 1/20 0.37
SRC P12931 1/20 0.37
NPC1 O15118 1/20 0.37
TRPM4 Q8TD43 1/20 0.36
TDP1 Q9NUW8 2/20 0.36
MCL1 Q07820 3/20 0.36
ALDH2 P05091 1/20 0.36
FFAR1 O14842 3/20 0.36
ITGB3 P05106 1/20 0.35
ITGB1 P05556 1/20 0.35
ITGAV P06756 1/20 0.35
ITGA5 P08648 1/20 0.35
TYK2 P29597 1/20 0.34
LMNA P02545 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7175700 0.94 L3MBTL1 (0.42) L3MBTL1KDM4EALDH1A1GAAMAPT
SCHEMBL7181815 0.92 L3MBTL1 (0.40) L3MBTL1KDM4EALDH1A1TDP1FFAR1
SCHEMBL7180843 0.90 L3MBTL1 (0.42) L3MBTL1KDM4EALDH1A1RAB9AMAPT
SCHEMBL7186458 0.90 ELANE (0.39) ALDH1A1RAB9AMAPTNPC1TRPM4
SCHEMBL7180509 0.89 FFAR1 (0.40) L3MBTL1KDM4EALDH1A1RAB9AGAA
SCHEMBL7189062 0.89 PPARG (0.40) L3MBTL1ALDH1A1MAPTTDP1MCL1
SCHEMBL7180541 0.88 THRB (0.40) MCL1
SCHEMBL7189393 0.87 THRB (0.42)
SCHEMBL7179737 0.87 KDM4E (0.39) L3MBTL1KDM4EALDH1A1RAB9AGAA
SCHEMBL7187585 0.87 S1PR1 (0.37) RAB9AMAPTNPC1TRPM4MCL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6579663-B2 Chemical intermediates such as lithium 2,6-dimethylbenzoyl phenylphosphine for preparation of acylphosphines, acylphosphine oxides or acylphosphine sulfides CIBA SPECIALTY CHEMICALS CORPORATION 2003-06-17 US disclosed
US-20020107413-A1 Organometallic monoacylarylphosphines WOLF JEAN-PIERRE (CH) 2002-08-08 US disclosed
US-6399805-B2 SUCH AS LITHIUM 2,6-DIMETHYLBENZOYLPHENYLPHOSPHINE, USE AS PHOTOINITIATORS IN PHOTOCURABLE COMPOSITIONS SUCH AS FOR PHOTOGRAPHIC PRODUCTION OF RELIEF IMAGES CIBA SPECIALTY CHEMICALS CORPORATION 2002-06-04 US disclosed
US-20010031898-A1 Organometallic monoacylarylphosphines CIBA SPECIALTY CHEMICALS CORP. 2001-10-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020107413-A1 Organometallic monoacylarylphosphines CBR1, NAF1, DHCR24 L3MBTL1 302/4885KDM4E 3226/4885ALDH1A1 3416/4885
US-20010031898-A1 Organometallic monoacylarylphosphines NAF1, DHCR24, CBR1 L3MBTL1 126/4885KDM4E 2651/4885ALDH1A1 3984/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.